Life Sciences
The company will use the funds to enhance the development of its AI capabilities and for commercial growth.
Vitalchat also garnered $6 million in a Series A round, and Cerula Care secured $3.7 million in an oversubscribed seed funding round.
The alliance will result in the integration of Kyruus Health's care access platform with aha!'s "low-code/no-code" health experience platform.
Kauvery Hospital invests in Lifesigns
Lifesigns has received undisclosed funding from Kauvery Hospital Group's investment arm, Healthcare Capital.
The bill would allow AI to be classified as a "practitioner licensed by law" to administer FDA-approved drugs.
Everly Health Solutions alleged that Walgreens broke the terms of a 2020 business contract during the COVID-19 pandemic.
The aim of Conduent's Maven is to help epidemiologists detect, monitor, track and report health threats.
The initiative brings together more than 60 companies in Europe and aims to "unlock Europe's full potential in AI."
Vik Bajaj, CEO of Foresite Labs and managing director of Foresite Capital, discusses how AI is used to develop personalized cancer vaccines - and the challenges and promises of Project Stargate.
Also, fitness technology company GOQii has introduced an AI-powered post-organ transplant care programme.